close_bt
img
close_bt
THE ENTEROBIOME

OUR VISION

VISION

OUR VISION

From around 15 years ago, many bacterial species among human gut microbiome have been identified as candidates with large impact on human health.

We are developing microbiome drugs or health functional food using strains with outstanding efficacy and safety selected from our world-scale microbiome library. Furthermore, we have successfully developed cultivation solution for mass production of extremely oxygen-sensitive and hardly cultivable gut bacteria.

We plan to stand out as a leading microbiome company through the completion of cGMP grade plant in 2025 for pharmaceutical production.